Quanterix (QTRX) news
Recent news
Quebecor Inc.: National Bank of Canada cuts target price to C$71 from C$74
National Bank of Canada has revised its target price for Quebecor Inc. (TSE:QBR.B) to C$71 from C$74, reflecting a slight downward adjustment in its valuation outlook for the company. The move suggests a recalibration of expectations, potentially influenced by recent market dynamics or internal…
AInvest Wire · 2d agoAlzpath & Quanterix expand licensing pact for Ptau217
AInvest Wire · Oct 7, 2026Quanterix' Simoa gets NMPA approval in China
Quanterix Corporation has announced that its Simoa technology has received approval from China’s National Medical Products Administration (NMPA), marking a significant regulatory milestone for the company in the Chinese market. The NMPA, which oversees the approval and regulation of medical devices…
AInvest Wire · Oct 7, 2026Quanterix & Innovita expand IVD access in China
Quanterix and Innovita have expanded their collaboration to enhance in vitro diagnostic (IVD) access in China, a market increasingly focused on neurodegenerative disease detection and management. With China’s aging population projected to see Alzheimer’s and dementia cases rise from 15 million…
AInvest Wire · Oct 7, 2026Quanterix Corporation - Innovita plans regulatory submissions for additional Quanterix biomarker kits in China
AInvest Wire · Oct 7, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.